Peroxisome-associated Gene Family: PIGF as A Drug Target (G5281)

Target Name: PIGF

NCBI ID: G5281

PIGF

Peroxisome-associated Gene Family: PIGF as A Drug Target

Peroxisome-associated gene (PIG) 鈥嬧?媐amilies are a superfamily of evolutionarily conserved gene clusters that have been identified in various organisms, including humans. PIG families are characterized by the conservation of a characteristic gene structure, including a cDNA-like open reading frame (ORF ), a unique initiation codon, and a putative translation start site (TSS). PIG families are involved in a wide range of cellular processes, including cell signaling, DNA replication, and stress response.

PIGF, also known as PIGF variant 1, is a gene that belongs to the PIG family and has been identified as a potential drug target in various diseases, including cancer. In this article, we will explore the biology of PIGF and its potential as a drug target.

PIGF: Structure and Function

PIGF is a gene that encodes a protein known as PIGF-伪 (Peroxisome-associated gene family 伪). The PIGF-伪 protein is a 21-kDa protein that is expressed in various tissues and cells of the body. PIGF-伪 plays a critical role in the regulation of cellular processes, including cell signaling, DNA replication, and stress response.

PIGF-伪 is a cytoplasmic protein that is involved in the detoxification of xenobiotics, such as toxins and malware, by the peroxisome. Peroxisomes are organelles that are responsible for the detoxification of harmful substances in the body, and PIGF-伪 is a key component of this process.

PIGF-伪 is also involved in the regulation of cellular signaling pathways, including the TGF-β pathway. TGF-β is a well-known developmental signaling pathway that is involved in the regulation of cellular processes, including cell growth, differentiation, and stress response. PIGF-伪 has been shown to play a critical role in the regulation of TGF-β signaling by interacting with the transcription factor SMAD2.

PIGF-伪 is also involved in the regulation of DNA replication, which is a critical process for the maintenance of genetic diversity in the population. PIGF-伪 has been shown to play a critical role in the regulation of DNA replication by interacting with the enzyme DNA polymerase II.

PIGF-伪 is also involved in the regulation of stress response, which is a critical process for the survival of the body in the face of environmental stressors. PIGF-伪 has been shown to play a critical role in the regulation of stress response by interacting with the transcription factor ATF2.

PIGF-伪 as a Drug Target

PIGF-伪 has been identified as a potential drug target due to its involvement in various cellular processes that are involved in the development and progression of diseases. PIGF-伪 has been shown to play a critical role in the regulation of cancer cell growth, and it has been shown to be involved in the development of various types of cancer, including breast, lung, and ovarian cancer.

PIGF-伪 has also been shown to play a critical role in the regulation of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. PIGF-伪 has also been shown to interact with the protein huntingtin, which is a neurodegenerate protein that is involved in the development of neurodegenerative diseases.

PIGF-伪 has also been shown to play a critical role in the regulation of inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease. PIGF-伪 has also been shown to interact with the transcription factor nuclear factor kappa B (NF

Protein Name: Phosphatidylinositol Glycan Anchor Biosynthesis Class F

Functions: Involved in GPI-anchor biosynthesis (PubMed:33386993). It acts through the transfer of ethanolamine phosphate to the third mannose of GPI

The "PIGF Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PIGF comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets